Fastener distributor Fastenal (Nasdaq: FAST) kicks off the new trading week with its third-quarter report. Wall Street expects earnings to climb 24% to $0.51 a share. That's a welcome growth rate in this nervous environment, but Fastenal should be good for it. The company has topped analyst estimates in each of the past three quarters.

Earnings season kicks in with a ton of quarterly reports. Tuesday's bellwethers include Intel (Nasdaq: INTC) on the tech side and Johnson & Johnson (NYSE: JNJ) on the Big Pharma side. Both companies are looking to post small bottom-line improvements over their year-ago performances.

Financial services take the spotlight on Wednesday, with JPMorgan Chase (NYSE: JPM) and Wells Fargo (NYSE: WFC) reporting. Quarterly showings by investment brokers and banking behemoths used to feel inconsequential. These days, they define the market. Will either company keep gobbling up distressed banks? You may not get a direct answer, but you'll probably appreciate the weigh-in anyway.

Intuitive Surgical
(Nasdaq: ISRG) should shine on Thursday. The maker of the revolutionary da Vinci surgical robotic arms has beaten Wall Street's quarterly expectations every time since the latter half of 2002. Will it short-circuit this time, or once again land well ahead of the $1.27-a-share profit target?

Energy exploration giant Schlumberger (NYSE: SLB) puts the exclamation point with its quarterly report on Friday. If you think the week ahead is busy, just wait until the following week.

Until next week, I remain,
Rick Munarriz

JPMorgan Chase and Johnson & Johnson are Motley Fool Income Investor selections. Intel is a Motley Fool Inside Value pick. Intuitive Surgical is a Motley Fool Rule Breakers recommendation. Try any of our Foolish newsletter service free for 30 days.

Longtime Fool contributor Rick Munarriz recommends windshield wiper fluid when trying to look forward. He does not own shares in any of the companies in this story. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Fool has a disclosure policy.